Sex and the treatment effect in the Chinese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES) trial


      • Among women, there was a trend for a higher proportion with good functional outcome with NeuroAiD versus placebo (p = 0.056).
      • There was no treatment difference between NeuroAiD versus placebo in men (p = 0.803).
      • A trend for an interaction between sex and treatment was detected (odds ratio 1.13, p = 0.075).


      In the randomized controlled trial of NeuroAiD versus placebo following ischemic stroke, there was a trend for sex influencing the treatment effect of NeuroAiD in improving functional outcome following ischemic stroke (p = 0.075).


      To read this article in full you will need to make a payment


        • Kent D.M.
        • Price L.L.
        • Ringleb P.
        • et al.
        Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
        Stroke. 2005; 36: 62-65
        • De Silva D.A.
        • Ebinger M.
        • Davis S.M.
        Gender issues in acute stroke thrombolysis.
        J Clin Neurosci. 2009; 16: 501-504
        • Reeves M.J.
        • Bushnell C.D.
        • Howard G.
        • et al.
        Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.
        Lancet Neurol. 2008; 7: 915-926
        • Venketasubramanian N.
        • Chen C.L.H.
        • Gan R.N.
        • et al.
        A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study).
        Int J Stroke. 2009; 4: 54-60
        • Wu X.
        • Min L.
        • Cong L.
        • et al.
        Sex differences in health-related quality of life among adult stroke patients in Northeastern China.
        J Clin Neurosci. 2014; 21: 957-961
        • Chankrachang S.
        • Navarro J.C.
        • De Silva D.A.
        • et al.
        Prognostic factors and treatment effect in the CHIMES study.
        J Stroke Cerebrovasc Dis. 2015; 24: 823-827